Pharmacokinetics in End Stage Renal Disease Patients

Summary

The study is a multicentre, open label, phase I, two arms study to compare pharmacokinetic of firibastat after a single oral dose of firibastat 500 mg in fourteen healthy male volunteers and in fourteen End Stage Renal Disease (ESRD) patients not yet in dialysis.

Timeline

Start

2019-09-17

Primary completion

2020-07-10

Completion

2020-07-10

Drugs

Indications